We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Apparent Risk of Crohn's Disease After Appendectomy Explained

By HospiMedica staff writers
Posted on 31 Oct 2007
A new study suggests that an evident transient increased risk of Crohn's disease after an appendectomy may be attributable to diagnostic bias.

Researchers of the Statens Serum Institut (Copenhagen, Denmark) studied data on 443,761 Swedish appendectomy patients and 265,592 Danish appendectomy patients who were followed for first hospitalizations for Crohn's disease. More...
The median age at appendectomy was 26 years and the subjects were followed for an average of 15.6 years (11.1 million person-years). A total of 1655 Crohn's disease cases were observed during follow-up.

Overall, the standardized incidence ratio (SIR) of Crohn's disease after an appendectomy was 1.52. No association was observed between appendectomy before the age of 10 years and the risk of Crohn's disease (SIR 1.00). The highest risk of Crohn's disease was observed in the first 6 months after appendectomy (SIR 8.69). The risk of Crohn's disease diminished quickly after that, and the risk reached background levels five to ten years after the appendectomy. The study was published in the October 2007 issue of Gut.

"Patients who underwent an appendectomy with a non-inflamed appendix remained at a significantly elevated risk for up to 20 years,” concluded Dr. Morten Frisch, Ph.D., and colleagues of the epidemiology research unit. "These findings can be explained by well-known differential diagnostic problems that may result in unnecessary appendectomies in some patients who present with symptoms of incipient Crohn's disease. Such cases of Crohn's disease will probably come to the clinician's attention after the appendectomy, a bias that is likely to be most pronounced within the first few years after an appendectomy.”


Related Links:
Statens Serum Institut

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.